Our research encompasses understanding psychiatric disorders through studies in neurogenetics and neurochemistry; functional brain imaging across the lifespan; evaluating cognition deficits in schizophrenia; understanding the molecular and cellular basis of Alzheimer’s disease; early intervention for people at high risk; and culturally competent care.
Our focus is to diminish the impact of psychiatric illness by changing the landscape of brain health, and adding to the knowledge base — from genes and neurons, to drugs and receptors, to cultural understanding.
Two NKI investigators appear on the 2017 Clarivate Analytics list of Highly Cited Researchers. F. Xavier Castellanos, MD, and Michael Milham, MD, PhD, are both recognized for their contributions in the field of Neuroscience & Behavior. The selection criteria for this year’s list included authoring a high number of papers between 2005-2015 that rank in the top 1% by citations. (Click here for a more detailed description of the selection methodology.)